Skip to main content

Table 2 The distribution of biological markers, ET-1 concentration and ACE activity in patients and control subjects

From: Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients

Populations Biological parameters Patients (n = 157) Control subjects (n = 142) p
Glucose (x ± σmmolL/) 9.8 ± 4.2 5.40 ± 0.84 <0000.1
TC (x ± σmmol/L) 5.70 ± 3.1 4.60 ± 2.6 <0.00
HDL-C (x ± σmmol/L) 1.14 ± 0.22 1.30 ± 0.41 NS
LDL-C (x ± σmmol/L) 3.60 ± 2.16 2.80 ± 1.4 <0.001
TG (x ± σmmol/L) 1.60 ± 0.9 1.24 ± 0.3 NS
ApoA1 (x ± σ. g/L) 1.41 ± 0.62 1.80 ± 0.2 <0000.1
ApoB (x ± σ. g/L) 1.40 ± 0.81 0.70 ± 0.2 <0000.1
ET-1 (x ± σ. nM) 15.2 ± 5.3 7.1 ± 2.7 <0.00001
ACE (x ± σ. UI/L) 86.7 ± 25.4 42.8 ± 12.1 <0.00001
  1. NS not significant (p > 0.05)
  2. X mean
  3. σ standard deviation
  4. TC Total cholesterol
  5. HDL-C high density lipoprotein cholesterl
  6. LDL-C low density lipoprotein cholesterol
  7. TG triglycerides
  8. ApoA Apolipoprotein A
  9. ApoB Apolipoprotein B
  10. ET-1 Endothelin-1
  11. ACE Angiotensin-converting enzyme